Arcus Biosciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $222.0M | $150.0M | $127.0M | $206.0M | $148.0M | $173.4M | $57.9M | $71.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $1.01B | $1.02B | $831.0M | $1.07B | $1.26B | $735.8M | $192.7M | $258.9M |
| Property, Plant & Equipment | $40.0M | $47.0M | $51.0M | $35.0M | $32.0M | $10.8M | $9.3M | $11.1M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $1.14B | $1.15B | $1.10B | $1.35B | $1.59B | $772.3M | $203.1M | $274.9M |
| Liabilities | ||||||||
| Accounts Payable | $42.0M | $18.0M | $17.0M | $20.0M | $10.0M | $15.7M | $4.7M | $3.1M |
| Total Current Liabilities | $231.0M | $226.0M | $184.0M | $193.0M | $166.0M | $121.7M | $22.7M | $16.9M |
| Long-Term Debt | $99.0M | $48.0M | $0 | — | — | — | — | — |
| Total Liabilities | $508.0M | $665.0M | $633.0M | $688.0M | $750.4M | $270.0M | $39.3M | $40.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.49B | $-1.13B | $-849.0M | $-542.0M | $-275.0M | $-328.2M | $-205.3M | $-122.8M |
| Total Stockholders' Equity | $631.0M | $485.0M | $462.0M | $657.0M | $842.0M | $502.0M | $164.0M | $234.9M |